Xiaoqing Yu Selected Research

Xiaoqing Yu Research Topics

Disease

42	Neoplasms (Cancer) 05/2024 - 01/2005
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 05/2008
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2005
6	Lung Neoplasms (Lung Cancer) 04/2024 - 05/2008
6	Melanoma (Melanoma, Malignant) 01/2024 - 01/2018
5	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 08/2019
5	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2018
3	Carcinoma (Carcinomatosis) 11/2023 - 01/2021
3	Obesity 01/2023 - 01/2017
3	Esophageal Neoplasms (Esophageal Cancer) 11/2022 - 05/2008
3	Infections 12/2020 - 01/2017
2	Primary Myelofibrosis (Myelosclerosis) 05/2024 - 11/2018
2	Inflammation (Inflammations) 05/2024 - 09/2016
2	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2020
2	Fatty Liver 01/2024 - 09/2018
2	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 01/2023
2	Squamous Cell Carcinoma of Head and Neck 06/2023 - 07/2019
2	Mycosis Fungoides 01/2023 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 12/2012
2	Pneumonia (Pneumonitis) 01/2022 - 05/2008
2	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 01/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 01/2018
2	Chronic Disease (Chronic Diseases) 10/2018 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 01/2017
2	Patent Ductus Arteriosus 10/2016 - 01/2016
1	Penile Neoplasms (Penile Cancer) 05/2024
1	Glioblastoma (Glioblastoma Multiforme) 04/2024
1	Hyperthermia 03/2024
1	COVID-19 12/2023
1	Nasopharyngeal Carcinoma 06/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Endometriosis 01/2023
1	Tertiary Lymphoid Structures 11/2022
1	Endometrial Neoplasms (Endometrial Cancer) 03/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022

Drug/Important Bio-Agent (IBA)

11	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2017
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2018
9	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2018
8	ErbB Receptors (EGF Receptor)IBA 10/2023 - 04/2017
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2017
7	Immune Checkpoint InhibitorsIBA 01/2024 - 06/2017
4	Long Noncoding RNAIBA 03/2024 - 07/2019
4	Immunoglobulin A (IgA)IBA 11/2023 - 01/2021
3	Phosphotransferases (Kinase)IBA 05/2024 - 01/2018
3	Histones (Histone)IBA 04/2024 - 01/2016
3	LigandsIBA 04/2024 - 01/2005
3	VaccinesIBA 12/2023 - 01/2017
3	Immunoglobulin G (IgG)IBA 11/2023 - 03/2022
3	Carrier Proteins (Binding Protein)IBA 01/2023 - 09/2018
3	AntigensIBA 03/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2023
2	CollagenIBA 03/2024 - 02/2016
2	ChemokinesIBA 01/2024 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 11/2023 - 01/2021
2	AntibodiesIBA 01/2023 - 01/2021
2	Anaplastic Lymphoma KinaseIBA 01/2023 - 04/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2019
2	CateninsIBA 01/2022 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 01/2005
2	AndrogensIBA 11/2021 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2012
2	Small Cytoplasmic RNAIBA 01/2021 - 07/2019
2	NucleotidesIBA 12/2020 - 10/2017
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 01/2017
1	AlarminsIBA 05/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Notch ReceptorsIBA 04/2024
1	manganese ferriteIBA 03/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024
1	Butyric Acid (Butanoic Acid)IBA 01/2024
1	Histone Deacetylase InhibitorsIBA 01/2024
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2024
1	FucoseIBA 01/2024
1	Protein Isoforms (Isoforms)IBA 12/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2023
1	sintilimabIBA 10/2023
1	anlotinibIBA 10/2023
1	Cell-Free Nucleic AcidsIBA 06/2023
1	CD40 Ligand (CD40L)IBA 01/2023
1	SyndecansIBA 01/2023
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2023
1	InflammasomesIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2022
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 03/2022
1	C-Reactive ProteinIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	ProcalcitoninIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	ChromatinIBA 01/2022
1	CholesterolIBA 11/2021

Therapy/Procedure

17	Immunotherapy 04/2024 - 03/2015
12	Therapeutics 03/2024 - 01/2005
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Chemoradiotherapy 11/2022 - 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2023
1	Oncolytic Virotherapy 01/2023